Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, weight loss injections do have side effects — most are gastrointestinal, tend to be mild to moderate, and are typically at their worst in the first few weeks after starting or after a dose increase. They ease for the majority of people as the body adjusts. That said, some effects are serious enough to warrant prompt medical attention, so knowing the difference matters. Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines; a prescriber assesses your full health picture before any treatment begins, which is exactly where a detailed conversation about your personal risk profile should start. The NHS tirzepatide medicines page and the patient information leaflet supplied with every pen give the complete picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The framing that causes the most confusion is binary. Online, weight loss injections are either described as wonder treatments with barely a twinge of nausea, or as medicines so laden with risk they should be avoided entirely. Neither is accurate.
Tirzepatide and semaglutide have both been through large, rigorous clinical trials and been licensed by the MHRA specifically because their benefits in appropriate patients outweigh their risks. That does not mean side effects are rare, they are common, especially at the start. What it does mean is that for most people, those effects are manageable and time-limited, not a reason to stop without speaking to a prescriber first.
The honest middle ground: these are real medicines with a real side-effect profile. Most of what people experience is uncomfortable rather than dangerous. A small number of effects are serious. Learning which is which is far more useful than a verdict of "safe" or "scary". The full side-effect guide on our site breaks this down in more detail if you want to go deeper.
The side effects reported most often across both medicines are gastrointestinal. Nausea tops the list, followed by loose stools or diarrhoea, constipation, indigestion, reflux and burping. Fatigue and headache appear in trial data too, particularly in the first weeks. Injection-site reactions (mild redness, itching, a small lump) occur but are rarely a reason to stop.
Timing matters here. Symptoms are usually at their peak shortly after the first injection or after each dose step-up, and they often settle within one to two weeks as the body acclimatises. Many people find the nausea is worst in the hours after injecting; some manage this by injecting in the evening so the worst passes overnight.
Eating smaller portions, staying well hydrated, avoiding very fatty or rich meals, and not injecting on an empty stomach are all commonly reported to help, though your prescriber is the right person to tailor that advice to you. If you are specifically exploring B12 injections alongside your weight loss plan, it is worth reading about what side effects B12 injections for weight loss can bring before you begin. A useful overview of what to expect from these medicines is covered on the weight loss injection page.
People with diabetes using semaglutide-based treatments sometimes have additional considerations; the diabetes-specific side-effect page addresses those.
Most side effects do not need emergency attention. These ones do.
Acute pancreatitis is the one the MHRA specifically flagged in its January 2026 Drug Safety Update. The warning sign is severe stomach pain that comes on suddenly, may radiate through to the back, and does not ease quickly, sometimes accompanied by vomiting. If that describes what you are feeling, stop eating and seek urgent medical care. Do not try to manage it at home and do not wait until your next clinical check-in.
Other symptoms that warrant prompt medical contact include: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat); severe or persistent vomiting or diarrhoea leading to dehydration and inability to keep fluids down; symptoms of gallbladder problems such as upper-right abdominal pain after eating; and, particularly in people with diabetes, signs of very low blood sugar. If you are still weighing up whether to start treatment, our page on whether weight loss injections have side effects sets out the broader picture honestly. The MHRA Drug Safety Update index carries the full January 2026 communication on GLP-1 medicines and pancreatitis.
If you are unsure whether what you are experiencing is serious, NHS 111 is available around the clock. For anything that feels urgent, attend A&E.
The UK has a patient-facing reporting system specifically for this: the MHRA's Yellow Card scheme. You do not need a confirmed diagnosis or a doctor's referral to submit a report. If you suspect a medicine caused something, the scheme wants to hear it. That data is genuinely used to update safety guidance.
Clinical oversight reduces the risk of side effects being missed or mismanaged. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, your answers land on a prescriber's desk, not in an automated filter. That same prescriber re-reviews your case before every repeat order, which means no one is left on an increasing dose without a human clinical eye on how the previous one went. You can read more about our clinical team on the clinical team page.
If you are comparing the side-effect profiles of the two licensed injections, the detailed side-effect comparison covers them side by side. And if a concern arises between orders, our aftercare team is reachable seven days a week, details on the contact page.
These are prescription medicines. A prescriber discusses suitability and side effects as a standard part of the consultation at nume, speak to our prescribers to start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.